---
title: "Nexus Surgical and Medicare Ltd (538874) — Share Price, Financials & Analysis"
symbol: "538874"
company: "Nexus Surgical and Medicare Ltd"
canonical: "https://tapetide.com/stocks/538874"
isin: "INE370Q01015"
nse_symbol: "NEXUSSURGICALANDMEDICARELTD"
bse_code: "538874"
sector: "Financial Services"
industry: "Other Financial Services"
market_cap_cr: 18.34
generated_at: "2026-09-13T19:39:49.419Z"
---

# Nexus Surgical and Medicare Ltd (538874)

Canonical page: https://tapetide.com/stocks/538874

## Company

- **NSE Symbol:** NEXUSSURGICALANDMEDICARELTD
- **BSE Code:** 538874
- **ISIN:** INE370Q01015
- **Sector:** Financial Services
- **Industry:** Other Financial Services
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** nexusmed.co.in

## About

Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:40:14.355120Z.

- **Market Cap:** ₹18.34 Cr
- **Classification:** Microcap
- **P/E (reported):** 24.5
- **EPS (TTM):** ₹1.43
- **EPS (reported):** ₹0.39
- **Book Value:** ₹3.29
- **Price to Book:** 10.7
- **Dividend Yield:** 0%
- **ROE:** 46.76%
- **ROCE:** 62.79%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹7.87 Cr
- **Net Income:** ₹0.74 Cr
- **EBITDA:** ₹0.97 Cr
- **52-Week High:** ₹35.4
- **52-Week Low:** ₹13.26
- **RSI (14):** 74.69

## Tapetide Score

- **Score:** 66 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 97.4 (of 4473 scored stocks)
- **Confidence:** 94%
- **Data coverage:** 88%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 73.34 | 9% |
| growth | 74.73 | 9% |
| momentum | 98.3 | 12% |
| ownership | 50 | 24% |
| quality | 93.61 | 22% |
| valuation | 41.12 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 53.8%

### Weaknesses

- Stock is trading at 10.2 times its book value
- Promoter holding is low: 18.7%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 124.39% | -81.82% | -50% |
| ebitda margin growth | 0% | 4.69% | 46.89% | -24.06% |
| net income growth | 0% | 48% | 63% | 38% |
| revenue growth | 23.81% | 38.07% | 72% | 16% |
| roce | — | 22.3% | -3.15% | 46.82% |
| roe | — | 24.13% | 44.27% | -132.78% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.37 | 1.45 | 0.6 | 1.76 | 0.99 | 1.48 | 1.48 | 1.73 | 1.17 | 2.93 | 2.05 | 2.55 |
| Expenses | 0.28 | 1.4 | 0.52 | 1.64 | 0.71 | 1.33 | 1.37 | 1.53 | 0.94 | 2.71 | 1.75 | 2.31 |
| Operating Profit | 0.09 | 0.05 | 0.08 | 0.12 | 0.28 | 0.15 | 0.11 | 0.2 | 0.23 | 0.22 | 0.3 | 0.24 |
| OPM % | 24.32 | 3.45 | 13.33 | 6.82 | 28.28 | 10.14 | 7.43 | 11.56 | 19.66 | 7.51 | 14.63 | 9.41 |
| Other Income | 0.02 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.01 | 0.02 | 0.03 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.11 | 0.06 | 0.08 | 0.12 | 0.28 | 0.15 | 0.12 | 0.2 | 0.23 | 0.23 | 0.32 | 0.27 |
| Tax % | 27.27 | 33.33 | 25 | 25 | 25 | 26.67 | 25 | 25 | 26.09 | 26.09 | 25 | 25.93 |
| Net Profit | 0.08 | 0.05 | 0.06 | 0.09 | 0.21 | 0.11 | 0.09 | 0.15 | 0.17 | 0.17 | 0.24 | 0.2 |
| EPS in Rs | 0.15 | 0.09 | 0.11 | 0.16 | 0.38 | 0.2 | 0.16 | 0.27 | 0.31 | 0.31 | 0.44 | 0.37 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.98 | 2.14 | 1.73 | 3.74 | 2.4 | 1.55 | 3.47 | 5.72 | 7.87 | 8.7 |
| Expenses | 1.36 | 2.32 | 1.66 | 3.58 | 2.03 | 1.33 | 3.2 | 5.05 | 6.9 | 7.71 |
| Operating Profit | -0.38 | -0.18 | 0.07 | 0.16 | 0.37 | 0.22 | 0.27 | 0.67 | 0.97 | 0.99 |
| OPM % | -38.78 | -8.41 | 4.05 | 4.28 | 15.42 | 14.19 | 7.78 | 11.71 | 12.33 | 11.38 |
| Other Income | 0.06 | 0.08 | -5.35 | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | 0.03 | 0.06 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.32 | -0.1 | -5.28 | 0.17 | 0.39 | 0.23 | 0.29 | 0.67 | 0.99 | 1.05 |
| Tax % | 3.12 | 0 | 0.38 | 5.88 | 25.64 | 26.09 | 27.59 | 25.37 | 25.25 | — |
| Net Profit | -0.33 | -0.11 | -5.3 | 0.15 | 0.29 | 0.17 | 0.21 | 0.5 | 0.74 | 0.78 |
| EPS in Rs | -0.6 | -0.2 | -9.69 | 0.27 | 0.53 | 0.31 | 0.38 | 0.91 | 1.35 | 1.43 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves | 0 | -0.33 | -0.44 | -5.73 | -5.58 | -5.29 | -5.12 | -4.91 | -4.41 | -3.67 |
| Borrowings | 0.29 | 0.25 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.18 | 0.2 | 0.2 | 0.47 | 1.04 | 1.82 | 0.56 | 1.25 | 1.21 | 1.85 |
| Total Liabilities | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2 | 0.91 | 1.81 | 2.27 | 3.65 |
| Fixed Assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| CWIP | 5.35 | 5.35 | 5.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.56 | 0.22 | 0.12 | 0.19 | 0.91 | 1.99 | 0.89 | 1.79 | 2.25 | 3.63 |
| Total Assets | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2 | 0.91 | 1.81 | 2.27 | 3.65 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.17 | -0.07 | 0.02 | 0.24 | 0.2 | -0.11 | 0.55 | -0.41 | 0.1 | 0.17 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0 | -0.01 | 0 |
| Cash from Financing Activity | 0.2 | -0.04 | 0.01 | -0.26 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.03 | -0.11 | 0.03 | -0.02 | 0.2 | -0.11 | 0.54 | -0.42 | 0.1 | 0.17 |
| Free Cash Flow | -0.17 | -0.07 | 0.02 | 0.24 | 0.2 | -0.11 | 0.54 | -0.41 | 0.09 | 0.17 |
| CFO/OP | 94 | 18 | -11 | 343 | 125 | -30 | 250 | -152 | 15 | 18 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 292 | 37.24 | 6.82 | 0 | 11.71 | 0 | 9.42 | 78.89 | 85.51 | 61.22 |
| Inventory Days | 138.45 | 15.21 | 0 | 0 | 0 | — | 56.78 | 243.33 | 83.93 | 55.35 |
| Days Payable | 226.55 | 72.24 | — | — | — | — | 454.22 | 754.33 | 230.32 | 239.34 |
| Cash Conversion Cycle | 203.9 | -19.79 | 6.82 | 0 | 11.71 | 0 | -388.03 | -432.11 | -60.88 | -122.78 |
| Working Capital Days | -73 | -100.56 | -66.52 | -73.84 | -43.92 | -19.77 | -77.71 | 29.45 | 44.67 | 58.9 |
| ROCE % | -3.13 | -5.74 | -1.87 | 2.78 | — | 1114.29 | 86.79 | 65.93 | 83.95 | 69.93 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 48.29% | 48.43% | 45.61% | 44.37% | 44.31% | 44.07% | 44.64% | 44.54% | 44.02% | 43.88% | 43.42% | 41.9% |
| Others | 32.98% | 32.84% | 35.66% | 36.9% | 36.96% | 37.19% | 36.63% | 36.73% | 37.24% | 37.39% | 37.84% | 39.37% |
| No. of Shareholders | 3286 | 3417 | 4307 | 4201 | 5102 | 5866 | 6024 | 6137 | 6048 | 5997 | 5858 | 5743 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 4 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 28.38 | Buy |
| EMA (10) | 29.34 | Buy |
| SMA (20) | 24.07 | Buy |
| EMA (20) | 25.96 | Buy |
| SMA (50) | 21.1 | Buy |
| EMA (50) | 22.58 | Buy |
| SMA (100) | 20.8 | Buy |
| EMA (100) | 21.01 | Buy |
| SMA (200) | 18.93 | Buy |
| EMA (200) | 19.66 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 69.33 | Neutral |
| MACD (12,26,9) | 3.65 | Buy |
| Stochastic (14,3,3) | 89.43 | Sell |
| ADX (14) | 46.93 | Buy |
| Williams %R (14) | -11.18 | Sell |
| ATR (14) | 3.03 | High Volatility |
| ROC (12) | 53.14 | Buy |
| Stoch RSI (14) | 76.53 | Neutral |
| UO (7,14,28) | 62.59 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Notice Of The 35Th Annual General Meeting Of The Company To Be Held On Friday 25Th September 2026 At 12:30 P.M. Through Video Conferencing (VC)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6779d1ba-953b-4aeb-8622-824fecaf0327.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4776fd77-e737-4c50-92f8-a82df7b0f90f.pdf) |
| 2026-09-03 | [Reply On Clarification Sought By Exchange](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2e959ca-613e-4ac2-b9a8-7c7e7034e5fb.pdf) |
| 2026-09-02 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 2Nd September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f84e0ad-170b-4ad8-9c8b-1e815bd17997.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Resignation of Managing Director](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40462928-a101-4065-b0be-279b900d409d.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7271238f-f4da-4455-82b4-eb77f89cd483.pdf) |
| 2026-09-02 | [Announcement Under Regulation 30 - Appointment Of Independent Director For A Period Of 5 Years](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe4be77b-144a-4325-85c5-5bdfa7a585a5.pdf) |
| 2026-09-02 | [Announcement Under Regulation 30 - Reappointment Of Independent Director For A Second Term Of 5 Years](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2042e57f-98b6-4457-99ce-3034a5a6cfdc.pdf) |
| 2026-09-02 | [Announcement Under Regulation 30 - Reconstitution Of Committees](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5c80104-2bcb-43a9-802e-2024d97200de.pdf) |
| 2026-09-02 | [Annual General Meeting To Be Held On Friday 25Th September 2026 At 12:30 P.M. Through Video Conferencing (VC)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4e0214a-fc26-481d-8f56-ec106a2996b3.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Results - Financial Results For 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cab76dfb-1906-48de-8e00-eea29e741968.pdf) |
| 2026-05-28 | [Results - Financial Results For 31-03-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1238879-40c1-4849-8cf0-1e34501fe1ba.pdf) |
| 2026-02-14 | [Results - Financial Results For 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04eac35e-7995-4990-92e8-ea7ea418026f.pdf) |
| 2025-11-14 | [Results - Financial Results For 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=564a559a-0b8c-4756-a1b3-f4f452c684bf.pdf) |
| 2025-08-14 | [Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dffa55b8-a456-4658-b875-077459d1c296.pdf) |
| 2025-05-30 | [Results- Financial Results For The Quarter And Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=938f6a59-5c8b-4d9b-ba80-a7cd2676b543.pdf) |
| 2025-01-21 | [Financial Results For The Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62262c00-9811-4230-a1e7-e87ba04e62c9.pdf) |
| 2024-11-14 | [Results - Financial Results For 30-09-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d497880-982c-4be7-a3a1-f440d55e456a.pdf) |
| 2024-08-13 | [Financial Results For The Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc473f6a-341b-42f2-8c4a-7a3d74775cef.pdf) |
| 2024-05-30 | [Results - Financial Results For 31-03-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c2de575-090e-4f6f-bbec-5f1e60338e8f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026; no dematerialisation cases reported. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026; no dematerialisation cases reported.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b7842cf8-7733-49ad-9915-d43f17994985.pdf) |
| 7 Feb - Board meeting 14 Feb 2026: approve unaudited results for quarter ended 31 Dec 2025; trading window closed till 16 Feb. | [Board Meeting Intimation for Nexus Surgical And Medicare Limited Scheduled Its Board Meeting On Saturday 14Th February,2026 At 03:30 P.M. At The Registered Office Of The Company 7 Feb - Board meeting 14 Feb 2026: approve unaudited results for quarter ended 31 Dec 2025; trading window closed till 16 Feb.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/39b3ff52-8733-4463-8540-8f81a3ce229e.pdf) |
| 5 Jan - Certificate under Reg 74(5) for quarter ended 31-Dec-2025; no dematerialisations reported. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Jan - Certificate under Reg 74(5) for quarter ended 31-Dec-2025; no dematerialisations reported.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a08338d1-a0b9-4639-a91f-4944300d2470.pdf) |
| 3 Mar - Assam issued LoI to partner InstaPe for provisional empanelment to provide salary-linked loans; MoU and integration pending. | [Clarification Pursuant To The Press Release Issued On March 01, 2026 3 Mar - Assam issued LoI to partner InstaPe for provisional empanelment to provide salary-linked loans; MoU and integration pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07abb0e5-6a47-4701-b035-3a45373e1f87.pdf) |
| 3 Jan - 3 Jan 2026: Nexus Surgical states price movement market-driven; no undisclosed price-sensitive information. | [Reply On Clarification Sought By Exchange 3 Jan - 3 Jan 2026: Nexus Surgical states price movement market-driven; no undisclosed price-sensitive information.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16aa82fa-de41-45bd-a194-881fe6c1d3ef.pdf) |
| 18 Feb - Newspaper publication for Notice of Postal Ballot | [Announcement under Regulation 30 (LODR)-Newspaper Publication 18 Feb - Newspaper publication for Notice of Postal Ballot](https://www.bseindia.com/xml-data/corpfiling/AttachHis/750c0e4a-5cbf-4c48-a9e5-aa9a06763f23.pdf) |
| 18 Feb - In-principle approval to issue 34,303,482 equity shares and 7,653,061 warrants (preferential), Feb 18, 2026. | [Intimation Of In-Principle Approval Received For Issue And Allotment Of 3,43,03,482 Equity Shares And 76,53,061 Warrants To Be Issued On A Preferential Basis 18 Feb - In-principle approval to issue 34,303,482 equity shares and 7,653,061 warrants (preferential), Feb 18, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b630b657-04aa-4c20-b7e4-6cb1417a455c.pdf) |
| 14 Feb - Please Find the attached intimation for Newspaper Publication. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb - Please Find the attached intimation for Newspaper Publication.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/391d6030-4bed-47e8-9a33-90eea94e646b.pdf) |
| 14 Feb - Board approved Q3/9M FY26 unaudited results: Q3 revenue Rs293.65L, 9M revenue Rs582.75L, Q3 profit Rs17.01L. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 14Th February, 2026 14 Feb - Board approved Q3/9M FY26 unaudited results: Q3 revenue Rs293.65L, 9M revenue Rs582.75L, Q3 profit Rs17.01L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8456a575-9c1f-4380-b97f-dd5209d7590d.pdf) |
| 13 Feb - Board approved unaudited Q3 Dec 31, 2025 results; NCD asset cover certified; postal ballot for AOA nominee director. | [Board Meeting Outcome for Outcome Of The Board Meeting 13 Feb - Board approved unaudited Q3 Dec 31, 2025 results; NCD asset cover certified; postal ballot for AOA nominee director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6f3a176-1fae-4176-a486-9d59c8322ce4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fd90a6dc-ea35-4ed0-80ea-17e6973808ab.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbb367cc-3bd9-4c3e-bc79-f4495dca9efd.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1845b532-da0a-403c-9a53-3e79d02ae817.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34f6d0ad-bab3-49ad-84f8-9b68093f2df9.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e5138d0b-f5df-4b5a-bdfe-fbe6527b31b6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d25e87c-d448-433d-ac38-ca153027ebce.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542774/76176542774.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/538874/76511538874.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542774/71367542774.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/538874/71258538874.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:49.419Z.